# Quench Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quench-bio

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.quenchbio.com.
- Total disclosed funding: $50M
- Latest round: Series A (Jan 27, 2020)
- Investors on record: 4

## About

Founded in 2018 and based in Massachusetts, US, Quench Bio, Inc. is a company that develops molecule drugs and therapies that focuses on auto-immune and inflammation arena.

## Funding rounds

- Series A, Jan 27, 2020, $50M — Atlas Venture, AbbVie Ventures, RA Capital Management, Arix Bioscience
- Seed, Jun 1, 2018 — Atlas Venture, Arix Bioscience

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Seed, Series A
- Arix Bioscience (https://capitalatlas.ai/funds/arix-bioscience) — Seed, Series A
- AbbVie Ventures (https://capitalatlas.ai/funds/abbvie-ventures) — Series A
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A